Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease - PubMed (original) (raw)
doi: 10.1002/ana.24235. Epub 2014 Oct 16.
Dacia Dalla Libera, Edoardo Gioele Spinelli, Annamaria Finardi, Elisa Canu, Alessandra Bergami, Luisella Bocchio Chiavetto, Manuela Baronio, Giancarlo Comi, Gianvito Martino, Michela Matteoli, Giuseppe Magnani, Claudia Verderio, Roberto Furlan
Affiliations
- PMID: 25087695
- DOI: 10.1002/ana.24235
Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease
Federica Agosta et al. Ann Neurol. 2014 Dec.
Abstract
Objectives: We have described cerebrospinal fluid (CSF) myeloid microvesicles (MVs) as a marker of microglia activation during neuroinflammation in Alzheimer disease (AD), and characterized their ability to produce toxic amyloid β1-42 (Aβ1-42 ) oligomers from aggregated or soluble substrate. The aim of this study is to investigate the association of CSF myeloid MVs with neuroimaging, clinical, and paraclinical data in AD and mild cognitive impairment (MCI).
Methods: We collected CSF from 106 AD patients, 51 MCI patients, and 29 neurologically healthy controls. We examined CSF myeloid MV content and AD markers. A subgroup of 34 AD and 21 MCI patients underwent structural and diffusion tensor MRI.
Results: Higher levels of myeloid MVs were found in the CSF of AD patients and MCI patients converting within 3 years relative to controls, but also, at a lower level, in MCI patients not converting to AD. CSF myeloid MVs were associated with Tau but not with Aβ1-42 CSF levels. CSF MVs levels correlated with white matter (WM) tract damage in MCI, and with hippocampal atrophy in AD.
Interpretation: Microglial MVs are neurotoxic and myelinotoxic in the presence of Aβ1-42 . CSF myeloid MVs, mirroring microglia activation and MV release, are associated with WM damage in MCI and hippocampal atrophy in AD. This suggests that hippocampal microglia activation, in the presence of Aβ1-42 in excess, produces neurotoxic and oligodendrotoxic oligomers that, through WM tract damage, spread disease to neighboring and connected areas, causing local microglia activation and propagation of disease through the same sequence of events. Ann Neurol 2014;76:813-825.
© 2014 American Neurological Association.
Similar articles
- Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
Parnetti L, Chiasserini D, Eusebi P, Giannandrea D, Bellomo G, De Carlo C, Padiglioni C, Mastrocola S, Lisetti V, Calabresi P. Parnetti L, et al. J Alzheimers Dis. 2012;29(1):229-38. doi: 10.3233/JAD-2011-111349. J Alzheimers Dis. 2012. PMID: 22232006 - Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC, Hirni DI, Taylor KI, Berres M, Regeniter A, Gass A, Monsch AU, Sollberger M. Egli SC, et al. J Alzheimers Dis. 2015;44(2):625-33. doi: 10.3233/JAD-141716. J Alzheimers Dis. 2015. PMID: 25322924 - Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.
Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L'Italien G, van der Flier W, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ. Vos S, et al. Neurobiol Aging. 2012 Oct;33(10):2272-81. doi: 10.1016/j.neurobiolaging.2011.12.017. Epub 2012 Jan 20. Neurobiol Aging. 2012. PMID: 22264648 - Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hårdemark HG, Frisoni GB. Drago V, et al. J Alzheimers Dis. 2011;26 Suppl 3:159-99. doi: 10.3233/JAD-2011-0043. J Alzheimers Dis. 2011. PMID: 21971460 Review. - Blood and CSF chemokines in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.
Zhou F, Sun Y, Xie X, Zhao Y. Zhou F, et al. Alzheimers Res Ther. 2023 Jun 8;15(1):107. doi: 10.1186/s13195-023-01254-1. Alzheimers Res Ther. 2023. PMID: 37291639 Free PMC article. Review.
Cited by
- Propagation of pathology through brain networks in neurodegenerative diseases: from molecules to clinical phenotypes.
Agosta F, Weiler M, Filippi M. Agosta F, et al. CNS Neurosci Ther. 2015 Oct;21(10):754-67. doi: 10.1111/cns.12410. Epub 2015 Jun 1. CNS Neurosci Ther. 2015. PMID: 26031656 Free PMC article. Review. - Micro Trojan horses: Engineering extracellular vesicles crossing biological barriers for drug delivery.
Zeng B, Li Y, Xia J, Xiao Y, Khan N, Jiang B, Liang Y, Duan L. Zeng B, et al. Bioeng Transl Med. 2024 Jan 11;9(2):e10623. doi: 10.1002/btm2.10623. eCollection 2024 Mar. Bioeng Transl Med. 2024. PMID: 38435823 Free PMC article. Review. - Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: a pilot study.
Sattarov R, Havers M, Orbjörn C, Stomrud E, Janelidze S, Laurell T, Mattsson-Carlgren N. Sattarov R, et al. Sci Rep. 2024 Oct 25;14(1):25419. doi: 10.1038/s41598-024-75406-0. Sci Rep. 2024. PMID: 39455624 Free PMC article. - Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease.
Gabrielli M, Prada I, Joshi P, Falcicchia C, D'Arrigo G, Rutigliano G, Battocchio E, Zenatelli R, Tozzi F, Radeghieri A, Arancio O, Origlia N, Verderio C. Gabrielli M, et al. Brain. 2022 Aug 27;145(8):2849-2868. doi: 10.1093/brain/awac083. Brain. 2022. PMID: 35254410 Free PMC article. - An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer's disease.
Hurwitz SN, Sun L, Cole KY, Ford CR 3rd, Olcese JM, Meckes DG Jr. Hurwitz SN, et al. J Neurosci Methods. 2018 Sep 1;307:210-220. doi: 10.1016/j.jneumeth.2018.05.022. Epub 2018 Jun 9. J Neurosci Methods. 2018. PMID: 29894726 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical